What is the FII and DII shareholding of Glenmark Pharma?

Foreign Institutional Investors (FIIs) own 21.51%. Domestic Institutional Investors (DIIs) hold 2.02% of Glenmark Pharma.

What is the retail shareholding of Glenmark Pharma?

The retail shareholding of Glenmark Pharma is 14.21%

The shareholding pattern of Glenmark Pharma is updated quarterly as per SEBI regulations.

GLENMARK|532296|Pharmaceuticals

₹2,382.00₹2,382.00+₹83.30 (3.62%)

As on 02 Nov, 2026 | 15:57 IST

Shareholding Pattern

Promoters (46.65%)	Mutual funds (15.61%)	Retail and other (14.21%)
FII (21.51%)	Other DII (2.02%)

Promoters

Category	Sep 2026	Jun 2026	Mar 2026	Dec 2025
Promoters	46.65%	46.65%	46.65%	46.65%
FII	21.51%	20.89%	20.34%	19.20%
Other DII	2.02%	1.85%	2.49%	2.23%
Retail and other	14.21%	13.85%	13.72%	14.06%
Mutual funds	15.61%	16.76%	16.80%	17.86%

The promoters of Glenmark Pharma currently hold 46.65% of the company’s total shares.